Five Prime Therapeutics Inc (FPRX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO, CA 94080

Five Prime Therapeutics, Inc. provides clinical stage biotech services. The company discovers and develops a complete range of innovative protein and antibody therapeutics, as well as offers drugs for oncology and immunology diseases. FivePrime conducts business throughout the United States and Canada.

Data as of 2021-05-01 10:51:46 -0400
Market Cap0 Shares Outstanding46.572 Million Avg 30-day Volume0
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low0.0 / 0.0 Next Earnings Date Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from FPRX instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 0 1 (0.06%) 0 (0.0%)
Funds Holding: 125 93 34.41% 52 (3.12%) 38 (2.36%) 36.84%
13F shares: 39.038 Million 26.227 Million 48.85% 24.593 Million 18.903 Million 30.1%
% Ownership 84.2834 68.95 22.24% 53.0961 49.6947 6.84%
New Positions: 53 8 562.5% 25 2 1150.0%
Increased Positions 41 24 70.83% 15 13 15.38%
Closed Positions 21 12 75.0% 11 4 175.0%
Reduced Positions 24 33 -27.27% 11 13 -15.38%
Total Calls 285.093 Thousand 46.239 Thousand 516.56% 91.1 Thousand 0
Total Puts 244.322 Thousand 33 Thousand 640.37% 47.9 Thousand
PUT/CALL Ratio 0.86 0.71 21.13% 0.53 -25.35%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding FPRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding FPRX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BERGER FRANKLIN M

  • Director
0 2021-04-16 2

JENSEN PEDER

  • Director
0 2021-04-16 2

DHINGRA KAPIL

  • Director
0 2021-04-16 2

NICHOLSON GARRY A

  • Director
0 2021-04-16 2

SMITH DAVID V EXECUTIVE VICE PRESIDENT & CFO

  • Officer
0 2021-04-16 5

WHITE DAVID SEE REMARKS

  • Officer
0 2021-04-16 4

SCHAFER CAROL

  • Director
0 2021-04-16 2

LYONS-WILLIAMS LORI

  • Director
0 2021-04-16 2

CIVIK THOMAS PRESIDENT AND CEO

  • Officer
  • Director
0 2021-04-16 2

RINGO WILLIAM R

  • Director
0 2021-04-05 3

SARENA FRANCIS WILLARD CHIEF STRATEGY OFFICER

  • Officer
123,927 2021-04-01 5

COLLINS HELEN LOUISE EVP AND CHIEF MEDICAL OFFICER

  • Officer
0 2021-03-31 6

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BVF I GP LLC

BIOTECHNOLOGY VALUE FUND II LP

BVF II GP LLC

BIOTECHNOLOGY VALUE TRADING FUND OS LP

BVF PARTNERS OS LTD.

BVF GP HOLDINGS LLC

BVF INC/IL

LAMPERT MARK N

  • 10% Owner
  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
6,262,085 2021-03-04 1

BVF GP HOLDINGS LLC

BVF I GP LLC

BVF II GP LLC

  • 10% Owner
  • SEE EXPLANATION OF RESPONSES
7,008,781 2020-05-14 1

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BIOTECHNOLOGY VALUE TRADING FUND OS LP

BVF PARTNERS OS LTD.

BVF INC/IL

LAMPERT MARK N

  • 10% Owner
  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
536,608 2019-12-20 0

KNICKERBOCKER ARON MARC PRESIDENT & CEO

  • Officer
  • Director
242,356 2019-09-01 0

WILLIAMS LEWIS T

  • Director
455,336 2019-09-01 0

IRVING BRYAN EVP, CHIEF SCIENTIFIC OFFICER

  • Officer
30,533 2019-05-15 0

WILLIAMS LEWIS T EXECUTIVE CHAIRMAN

WILLIAMS LEWIS T EXECUTIVE CHAIRMAN

  • Officer
  • Director
465,430 2018-11-05 0

MCDADE MARK

  • Director
0 2018-05-10 0

GUJRATHI SHEILA

  • Director
0 2018-05-10 0

RUBINSTEIN LINDA M INTERIM CFO

  • Officer
0 2018-04-13 0

BELSKY MARC SENIOR VICE PRESIDENT AND CFO

  • Officer
60,472 2018-02-26 0

BAKER KEVIN PAUL SVP, DEVELOPMENT SCIENCES

  • Officer
78,184 2018-02-26 0

COHEN FRED E

  • Director
0 2017-05-10 0

SIKORSKI ROBERT STEVEN SVP AND CHIEF MEDICAL OFFICER

  • Officer
104,158 2017-03-01 0

BORGES LUIS SVP, RESEARCH

  • Officer
64,888 2017-03-01 0

DOUGLAS R LEE

  • Director
16,862 2016-10-12 0

HAMBLETON JULIE EVP & CHIEF MEDICAL OFFICER

  • Officer
86,575 2015-11-11 0

ADAGE CAPITAL PARTNERS GP LLC

ADAGE CAPITAL PARTNERS, L.P.

ADAGE CAPITAL ADVISORS, L.L.C.

ATCHINSON ROBERT

GROSS PHILLIP

  • 10% Owner
No longer subject to file 2015-10-15 0

ATWOOD BRIAN G

  • Director
0 2015-06-12 0

WONG BRIAN RUSSELL SVP, RESEARCH

  • Officer
22,738 2015-06-12 0

KAVANAUGH WILLIAM MICHAEL SVP & CHIEF SCIENTIFIC OFFICER

  • Officer
0 2014-08-22 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

RINGO WILLIAM R - Director

2021-04-19 19:46:08 -0400 2021-04-16 D 10,000 d 0 direct

SMITH DAVID V - Officer EXECUTIVE VICE PRESIDENT & CFO

2021-04-19 19:57:02 -0400 2021-04-16 D 90,000 d 0 direct

BERGER FRANKLIN M - Director

2021-04-19 19:42:33 -0400 2021-04-16 D 10,000 d 0 direct

BERGER FRANKLIN M - Director

2021-04-19 19:42:33 -0400 2021-04-16 D 5,000 $38.00 d 0 direct

SMITH DAVID V - Officer EXECUTIVE VICE PRESIDENT & CFO

2021-04-19 19:57:02 -0400 2021-04-16 A 66,000 a 138,947 direct

DHINGRA KAPIL - Director

2021-04-19 19:39:43 -0400 2021-04-16 D 10,000 d 0 direct

COLLINS HELEN LOUISE - Officer EVP AND CHIEF MEDICAL OFFICER

2021-04-19 19:53:58 -0400 2021-04-16 D 20,000 d 0 direct

SARENA FRANCIS WILLARD - Officer CHIEF STRATEGY OFFICER

2021-04-19 20:04:26 -0400 2021-04-16 D 90,000 d 0 direct

COLLINS HELEN LOUISE - Officer EVP AND CHIEF MEDICAL OFFICER

2021-04-19 19:53:58 -0400 2021-04-16 D 60,000 d 0 direct

JENSEN PEDER - Director

2021-04-19 19:35:28 -0400 2021-04-16 D 20,000 d 0 direct

SARENA FRANCIS WILLARD - Officer CHIEF STRATEGY OFFICER

2021-04-19 20:04:26 -0400 2021-04-16 D 45,000 d 0 direct

JENSEN PEDER - Director

2021-04-19 19:35:28 -0400 2021-04-16 D 10,000 d 0 direct

SARENA FRANCIS WILLARD - Officer CHIEF STRATEGY OFFICER

2021-04-19 20:04:26 -0400 2021-04-16 D 3,209 d 0 direct

WHITE DAVID - Officer SEE REMARKS

2021-04-19 19:49:04 -0400 2021-04-16 D 33,423 $38.00 d 0 direct

NICHOLSON GARRY A - Director

2021-04-19 19:32:22 -0400 2021-04-16 D 20,000 d 0 direct

SARENA FRANCIS WILLARD - Officer CHIEF STRATEGY OFFICER

2021-04-19 20:04:26 -0400 2021-04-16 D 4,747 d 0 direct

RINGO WILLIAM R - Director

2021-04-19 19:46:08 -0400 2021-04-16 D 37,998 d 0 direct

NICHOLSON GARRY A - Director

2021-04-19 19:32:22 -0400 2021-04-16 D 15,000 d 0 direct

SARENA FRANCIS WILLARD - Officer CHIEF STRATEGY OFFICER by child

2021-04-19 20:04:26 -0400 2021-04-16 D 795 $38.00 d 0 indirect

RINGO WILLIAM R - Director

2021-04-19 19:46:08 -0400 2021-04-16 D 50,367 d 0 direct

SCHAFER CAROL - Director

2021-04-19 19:28:40 -0400 2021-04-16 D 25,000 d 0 direct

RINGO WILLIAM R - Director

2021-04-19 19:46:08 -0400 2021-04-16 D 15,000 d 0 direct

CIVIK THOMAS - Director - Officer PRESIDENT AND CEO

2021-04-19 19:21:50 -0400 2021-04-16 D 480,000 d 0 direct

RINGO WILLIAM R - Director

2021-04-19 19:46:08 -0400 2021-04-16 D 12,500 d 0 direct

BERGER FRANKLIN M - Director

2021-04-19 19:42:33 -0400 2021-04-16 D 20,000 d 0 direct

BERGER FRANKLIN M - Director

2021-04-19 19:42:33 -0400 2021-04-16 D 10,000 d 0 direct

SMITH DAVID V - Officer EXECUTIVE VICE PRESIDENT & CFO

2021-04-19 19:57:02 -0400 2021-04-16 D 185,000 d 0 direct

DHINGRA KAPIL - Director

2021-04-19 19:39:43 -0400 2021-04-16 D 20,000 d 0 direct

COLLINS HELEN LOUISE - Officer EVP AND CHIEF MEDICAL OFFICER

2021-04-19 19:53:58 -0400 2021-04-16 D 90,000 d 0 direct

COLLINS HELEN LOUISE - Officer EVP AND CHIEF MEDICAL OFFICER

2021-04-19 19:53:58 -0400 2021-04-16 D 58,000 d 0 direct

DHINGRA KAPIL - Director

2021-04-19 19:39:43 -0400 2021-04-16 D 10,000 d 0 direct

SARENA FRANCIS WILLARD - Officer CHIEF STRATEGY OFFICER

2021-04-19 20:04:26 -0400 2021-04-16 D 90,000 d 0 direct

COLLINS HELEN LOUISE - Officer EVP AND CHIEF MEDICAL OFFICER

2021-04-19 19:53:58 -0400 2021-04-16 D 135,547 $38.00 d 0 direct

JENSEN PEDER - Director

2021-04-19 19:35:28 -0400 2021-04-16 D 15,000 d 0 direct

SARENA FRANCIS WILLARD - Officer CHIEF STRATEGY OFFICER

2021-04-19 20:04:26 -0400 2021-04-16 D 75,000 d 0 direct

WHITE DAVID - Officer SEE REMARKS

2021-04-19 19:49:04 -0400 2021-04-16 D 25,000 d 0 direct

JENSEN PEDER - Director

2021-04-19 19:35:28 -0400 2021-04-16 D 12,500 d 0 direct

SARENA FRANCIS WILLARD - Officer CHIEF STRATEGY OFFICER

2021-04-19 20:04:26 -0400 2021-04-16 D 12,063 d 0 direct

RINGO WILLIAM R - Director

2021-04-19 19:46:08 -0400 2021-04-16 D 27,769 d 0 direct

NICHOLSON GARRY A - Director

2021-04-19 19:32:22 -0400 2021-04-16 D 15,000 d 0 direct

SARENA FRANCIS WILLARD - Officer CHIEF STRATEGY OFFICER as utma custodian for child

2021-04-19 20:04:26 -0400 2021-04-16 D 795 $38.00 d 0 indirect

RINGO WILLIAM R - Director

2021-04-19 19:46:08 -0400 2021-04-16 D 40,868 d 0 direct

SCHAFER CAROL - Director

2021-04-19 19:28:40 -0400 2021-04-16 D 20,000 d 0 direct

SARENA FRANCIS WILLARD - Officer CHIEF STRATEGY OFFICER

2021-04-19 20:04:26 -0400 2021-04-16 D 169,468 $38.00 d 0 direct

RINGO WILLIAM R - Director

2021-04-19 19:46:08 -0400 2021-04-16 D 46,939 d 0 direct

LYONS-WILLIAMS LORI - Director

2021-04-19 19:25:16 -0400 2021-04-16 D 20,000 d 0 direct

RINGO WILLIAM R - Director

2021-04-19 19:46:08 -0400 2021-04-16 D 10,000 d 0 direct

CIVIK THOMAS - Director - Officer PRESIDENT AND CEO

2021-04-19 19:21:50 -0400 2021-04-16 D 68,971 $38.00 d 0 direct

RINGO WILLIAM R - Director

2021-04-19 19:46:08 -0400 2021-04-16 D 16,600 d 0 direct

SMITH DAVID V - Officer EXECUTIVE VICE PRESIDENT & CFO

2021-04-19 19:57:02 -0400 2021-04-16 D 90,000 d 0 direct

BERGER FRANKLIN M - Director

2021-04-19 19:42:33 -0400 2021-04-16 D 15,000 d 0 direct

BERGER FRANKLIN M - Director

2021-04-19 19:42:33 -0400 2021-04-16 D 12,500 d 0 direct

SMITH DAVID V - Officer EXECUTIVE VICE PRESIDENT & CFO

2021-04-19 19:57:02 -0400 2021-04-16 D 138,947 $38.00 d 0 direct

DHINGRA KAPIL - Director

2021-04-19 19:39:43 -0400 2021-04-16 D 15,000 d 0 direct

COLLINS HELEN LOUISE - Officer EVP AND CHIEF MEDICAL OFFICER

2021-04-19 19:53:58 -0400 2021-04-16 D 90,000 d 0 direct

COLLINS HELEN LOUISE - Officer EVP AND CHIEF MEDICAL OFFICER

2021-04-19 19:53:58 -0400 2021-04-16 D 50,000 d 0 direct

DHINGRA KAPIL - Director

2021-04-19 19:39:43 -0400 2021-04-16 D 25,000 d 0 direct

SARENA FRANCIS WILLARD - Officer CHIEF STRATEGY OFFICER

2021-04-19 20:04:26 -0400 2021-04-16 D 58,000 d 0 direct

COLLINS HELEN LOUISE - Officer EVP AND CHIEF MEDICAL OFFICER

2021-04-19 19:53:58 -0400 2021-04-16 A 66,000 a 135,547 direct

JENSEN PEDER - Director

2021-04-19 19:35:28 -0400 2021-04-16 D 10,000 d 0 direct

SARENA FRANCIS WILLARD - Officer CHIEF STRATEGY OFFICER

2021-04-19 20:04:26 -0400 2021-04-16 D 25,521 d 0 direct

WHITE DAVID - Officer SEE REMARKS

2021-04-19 19:49:04 -0400 2021-04-16 D 30,000 d 0 direct

JENSEN PEDER - Director

2021-04-19 19:35:28 -0400 2021-04-16 D 12,500 d 0 direct

SARENA FRANCIS WILLARD - Officer CHIEF STRATEGY OFFICER

2021-04-19 20:04:26 -0400 2021-04-16 D 9,142 d 0 direct

RINGO WILLIAM R - Director

2021-04-19 19:46:08 -0400 2021-04-16 D 52,408 d 0 direct

NICHOLSON GARRY A - Director

2021-04-19 19:32:22 -0400 2021-04-16 D 10,000 d 0 direct

SARENA FRANCIS WILLARD - Officer CHIEF STRATEGY OFFICER as utma custodian for child

2021-04-19 20:04:26 -0400 2021-04-16 D 795 $38.00 d 0 indirect

RINGO WILLIAM R - Director

2021-04-19 19:46:08 -0400 2021-04-16 D 49,552 d 0 direct

SCHAFER CAROL - Director

2021-04-19 19:28:40 -0400 2021-04-16 D 1,250 d 0 direct

SARENA FRANCIS WILLARD - Officer CHIEF STRATEGY OFFICER

2021-04-19 20:04:26 -0400 2021-04-16 A 66,000 a 169,468 direct

RINGO WILLIAM R - Director

2021-04-19 19:46:08 -0400 2021-04-16 D 34,451 d 0 direct

LYONS-WILLIAMS LORI - Director

2021-04-19 19:25:16 -0400 2021-04-16 D 25,000 d 0 direct

CIVIK THOMAS - Director - Officer PRESIDENT AND CEO

2021-04-13 13:05:30 -0400 2021-04-09 F 11,088 $37.94 d 68,971 direct 0.1318 0.1318 2 0.0 1

SARENA FRANCIS WILLARD - Officer CHIEF STRATEGY OFFICER

2021-04-19 20:04:26 -0400 2021-04-06 G 14,174 d 103,468 direct

RINGO WILLIAM R - Director

2021-04-19 19:46:08 -0400 2021-04-05 G 10,000 d 0 direct

SARENA FRANCIS WILLARD - Officer CHIEF STRATEGY OFFICER

2021-04-19 20:04:26 -0400 2021-04-05 G 2,460 d 117,642 direct

SARENA FRANCIS WILLARD - Officer CHIEF STRATEGY OFFICER

2021-04-19 20:04:26 -0400 2021-04-01 G 1,440 d 120,102 direct

SARENA FRANCIS WILLARD - Officer CHIEF STRATEGY OFFICER by child

2021-04-19 20:04:26 -0400 2021-04-01 G 795 a 795 indirect

SARENA FRANCIS WILLARD - Officer CHIEF STRATEGY OFFICER as utma custodian for child

2021-04-19 20:04:26 -0400 2021-04-01 G 795 a 795 indirect

SARENA FRANCIS WILLARD - Officer CHIEF STRATEGY OFFICER

2021-04-19 20:04:26 -0400 2021-04-01 G 2,385 d 121,542 direct

SARENA FRANCIS WILLARD - Officer CHIEF STRATEGY OFFICER as utma custodian for child

2021-04-19 20:04:26 -0400 2021-04-01 G 795 a 795 indirect

COLLINS HELEN LOUISE - Officer EVP AND CHIEF MEDICAL OFFICER

2021-04-19 19:53:58 -0400 2021-03-31 G 8,085 d 69,547 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
FIVEPRIME THERAPEUTICS INC FPRX 2021-04-16 22:15:03 UTC -0.4131 0.4731 250000
FIVEPRIME THERAPEUTICS INC FPRX 2021-04-16 21:45:03 UTC -0.4131 0.4731 250000
FIVEPRIME THERAPEUTICS INC FPRX 2021-04-16 21:15:02 UTC -0.4131 0.4731 250000
FIVEPRIME THERAPEUTICS INC FPRX 2021-04-16 20:45:03 UTC -0.2623 0.3223 250000
FIVEPRIME THERAPEUTICS INC FPRX 2021-04-16 20:15:04 UTC -0.2623 0.3223 250000
FIVEPRIME THERAPEUTICS INC FPRX 2021-04-16 19:45:03 UTC -0.2623 0.3223 250000
FIVEPRIME THERAPEUTICS INC FPRX 2021-04-16 19:15:03 UTC -0.2623 0.3223 250000
FIVEPRIME THERAPEUTICS INC FPRX 2021-04-16 18:45:03 UTC -0.2623 0.3223 250000
FIVEPRIME THERAPEUTICS INC FPRX 2021-04-16 18:15:03 UTC -0.2623 0.3223 250000
FIVEPRIME THERAPEUTICS INC FPRX 2021-04-16 17:45:03 UTC -0.2623 0.3223 250000
FIVEPRIME THERAPEUTICS INC FPRX 2021-04-16 17:15:03 UTC -0.2623 0.3223 250000
FIVEPRIME THERAPEUTICS INC FPRX 2021-04-16 16:45:02 UTC -0.395 0.455 250000
FIVEPRIME THERAPEUTICS INC FPRX 2021-04-16 16:15:03 UTC -0.395 0.455 250000
FIVEPRIME THERAPEUTICS INC FPRX 2021-04-16 15:45:03 UTC -0.395 0.455 250000
FIVEPRIME THERAPEUTICS INC FPRX 2021-04-16 15:15:03 UTC -0.395 0.455 250000
FIVEPRIME THERAPEUTICS INC FPRX 2021-04-16 14:45:03 UTC -0.395 0.455 250000
FIVEPRIME THERAPEUTICS INC FPRX 2021-04-16 14:15:02 UTC -0.395 0.455 250000
FIVEPRIME THERAPEUTICS INC FPRX 2021-04-16 13:45:03 UTC -0.395 0.455 250000
FIVEPRIME THERAPEUTICS INC FPRX 2021-04-16 13:15:03 UTC -0.395 0.455 250000
FIVEPRIME THERAPEUTICS INC FPRX 2021-04-16 12:45:02 UTC -0.395 0.455 250000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments